@article{11098,
  keywords = {Humans, *Bronchodilator Agents, Retrospective Studies, Financial Stress, Drug Therapy, Combination, Adrenergic beta-2 Receptor Agonists/therapeutic use, Muscarinic Antagonists/therapeutic use, Administration, Inhalation},
  author = {A. Czira and V. Banks and G. Requena and R. Wood and T. Tritton and R. Wild and C. Compton and A. Ismaila},
  title = {Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study},
  year = {2024},
  journal = {BMJ Open},
  volume = {14},
  edition = {2024/02/08},
  number = {2},
  pages = {e072361},
  isbn = {2044-6055},
  doi = {10.1136/bmjopen-2023-072361},
  note = {2044-6055
Czira, Alexandrosz
Orcid: 0000-0002-3395-6186
Banks, Victoria
Orcid: 0000-0002-0087-7641
Requena, Gema
Orcid: 0000-0002-1889-6656
Wood, Robert
Orcid: 0000-0002-6977-435x
Tritton, Theo
Wild, Rosie
Orcid: 0000-0002-9963-6441
Compton, Chris
Orcid: 0000-0002-7564-5343
Ismaila, Afisi
Orcid: 0000-0002-2876-8308
Journal Article
Research Support, Non-U.S. Gov't
England
BMJ Open. 2024 Feb 7;14(2):e072361. doi: 10.1136/bmjopen-2023-072361.},
  language = {eng},
}